Work

Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease

Year: 2024

Type: article

Abstract: Chronic kidney disease (CKD) is a relatively common condition in patients with type

Source: Pharmacological Research

DOI: 10.1016/j.phrs.2023.107055

Authors: Pasquale Mone, Germano Guerra, Angela Lombardi, Maddalena Illario, Antonella Pansini, Anna Marro, Salvatore Frullone, Alessandro Taurino, Daniela Sorriento, Veronica Verri, Guido Iaccarino, Gaetano Santulli

Institutions: University of Molise, Albert Einstein College of Medicine, University of Naples Federico II, University of Bari Aldo Moro

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,740

Funders: Diabetes Action Research and Education Foundation, European Commission, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

OpenAlex ID: W4390512016

FWCI: 7.213

Cites: 10

Cited by: 27

Related to: 10